Dem Glukagon ähnliches Peptid-2

Patent europeic · EP1231219 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1231219
Numer da la dumonda
EP01129072
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
11-04-1997
Publitgà
14-08-2002
Concedì
25-08-2010
Stritgà
10-04-2017
Motiv
Durada maximala cuntanschida
Classas IPC
C07K 14/605 (2006.01)
A61K 38/26 (2006.01)
G01N 33/68 (2006.01)
Prioritad
US 631273 12.04.1996
Derivà da
EP97916280
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 18-04-2017

    Durada maximala cuntanschida

    Published in Swissreg on 18.04.2017

  2. 25-08-2010

    Concedì

    Published in Swissreg on 25.08.2010

Partidas

Possessur

1149336 ONTARIO INC.

19 Fernwood Road, Toronto, Ontario M6B 3G3, CA

NPS Pharmaceuticals, Inc.

550 Hills Drive, 3rd Floor, Bedminster, NJ 07921, US

Inventur

Drucker, Daniel J.

Toronto, Ontario M6B 3G3, CA

Sumner-Smith, Martin

Bolton, Ontario L7E 3V4, CA

Crivici, Anna E.

Toronto, Ontario M6H 3B5, CA

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.